Search
Selected Filter
Displaying 31–40 of 305 research results
-
Opus Genetics to Launch Gene Therapy Clinical Trial for LCA5 Patients
Eye On the Cure Research NewsThe LCA5 gene therapy will be the first emerging Opus treatment to move into a human study
-
Editas Reports Results for 14 Participants in its Phase 1/2 CRISPR/Cas9 Clinical Trial for LCA10
Eye On the Cure Research NewsThe company is seeking a partner to move the LCA10 program forward
-
Recap of Retinal Disease News from the 2022 Meeting of the American Academy of Ophthalmology
Eye On the Cure Research NewsReports on emerging therapies for dry age-related macular degeneration (geographic atrophy), Stargardt disease, and X-linked retinitis pigmentosa are included
-
Atsena’s LCA-GUCY2D Gene Therapy Improves Vision in Phase 1/2 Clinical Trial
Eye On the Cure Research NewsThe company is planning to move the emerging treatment into a pivotal trial
-
Eye On the Cure Research News
Small data sets present challenges for developing rare disease AI tools
-
Iveric Bio’s Zimura for Advanced Dry AMD Meets Endpoint in Second Phase 3 Clinical Trial
Eye On the Cure Research NewsThe company plans to seek FDA approval for the emerging therapy in first quarter of 2023
-
Belite Bio Launching Phase 3 Clinical Trial for Stargardt Disease Drug
Eye On the Cure Research NewsThe company’s drug is designed to reduce accumulation of toxins that cause vision loss.
-
ProQR Seeking to Partner Ophthalmic Programs
Eye On the Cure Research NewsThe company is halting its clinical programs for LCA10 and USH2A as it seeks a new partner
-
Eye On the Cure Research News
Funding for the new grants was made possible by Foundation’s strong donor base and philanthropic partners
-
Eye On the Cure Research News
The emerging therapy is designed to restore vision for people with advanced retinal degenerative diseases
.png)
